The main pathological manifestation of HT involves the destruction of thyroid follicular epithelial cells, and IL-17 indirectly participates in the inflammatory response by stimulating the inflammatory mediators and T-cell proliferation, leading to the inflammatory response of thyroid tissues, generation of thyroid autoantibodies, and tissue damage [4]. The gene discussed is IL17A; the disease is hematocrit.